# OnCo record response-2 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/response-2/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "response-2", "NCT02038036" ;
  schema:name "RESPONSE-2"@en ;
  schema:description "RESPONSE-2 extended ruxolitinib's benefit to PV patients without an enlarged spleen: three times as many reached haematocrit control."@en ;
  schema:url <https://onco.cc/trials/response-2/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02038036> ;
  onco:status "positive" ;
  onco:tag "polycythaemia-vera", "mpn" ;
  onco:phase "3" ;
  schema:startDate "2014-03-25" ;
  onco:cancers <https://onco.cc/cancers/polycythaemia-vera/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/ruxolitinib/> ;
  onco:companies <https://onco.cc/companies/novartis/> .